Results 1 - 20 of 62 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Newspaper Article
|
|
Novartis in Advanced Talks to Buy Cytokinetics; Acquisition would be latest in a flurry of deals by pharmaceutical giants for hot biotechsThe Wall Street journal. Eastern edition, 2024-01-08Copyright 2024 Dow Jones & Company, Inc. All Rights Reserved. ;EISSN: 2574-9579Digital Resources/Online E-Resources |
| 2 |
Material Type: Newspaper Article
|
|
Novartis Nears Deal To Acquire Maker of Heart DrugThe Wall Street journal. Eastern edition, 2024-01-09Copyright 2024 Dow Jones & Company, Inc. All Rights Reserved. ;ISSN: 0099-9660 ;EISSN: 2574-9579Digital Resources/Online E-Resources |
| 3 |
Material Type: Newspaper Article
|
|
Ionis's Shares Fall After Co-Developer Opts Against a Late-Stage Trial; GlaxoSmithKline to consider options for Ionis-TTR drug once more data is available from other studiesThe Wall Street journal. Eastern edition, 2016-05-26(c) 2016 Dow Jones & Company, Inc. Reproduced with permission of copyright owner. Further reproduction or distribution is prohibited without permission. ;EISSN: 2574-9579Digital Resources/Online E-Resources |
| 4 |
Material Type: Newspaper Article
|
|
Bristol Agrees to Pay $13.1 Billion in Cash To Buy Biotech FirmThe Wall Street journal. Eastern edition, 2020-10-06Copyright 2020 Dow Jones & Company, Inc. All Rights Reserved. ;ISSN: 0099-9660 ;EISSN: 2574-9579Digital Resources/Online E-Resources |
| 5 |
Material Type: Newspaper Article
|
|
Bristol to Pay $13.1 Billion for Heart-Drug Maker MyoKardia; Bristol Myers Squibb, which sells leading treatments for lung cancer and multiple myeloma, agrees to buy biotech MyoKardia to bolster heart-drug offeringsThe Wall Street journal. Eastern edition, 2020-10-05Copyright 2020 Dow Jones & Company, Inc. All Rights Reserved. ;EISSN: 2574-9579Digital Resources/Online E-Resources |
| 6 |
Material Type: Newspaper Article
|
|
Alnylam Pharmaceuticals Inc at Canaccord Genuity Growth Conference - FinalFair Disclosure Wire, 2023-08-10Copyright CQ Roll Call Aug 10, 2023Digital Resources/Online E-Resources |
| 7 |
Material Type: Newspaper Article
|
|
Global Hypertrophic Cardiomyopathy Pipeline Market Insight Report 2022 Featuring Key Players in this Space - Novartis, Imbria Pharmaceuticals, Cytokinetics, MyoKardiaM2 Presswire, 2022-05-25COPYRIGHT 2022 Normans Media Ltd.Digital Resources/Online E-Resources |
| 8 |
Material Type: Newspaper Article
|
|
Global Hypertrophic Cardiomyopathy Pipeline Market Insight Report 2022 Featuring Key Players in this Space - Novartis, Imbria Pharmaceuticals, Cytokinetics, MyoKardia - ResearchAndMarkets.comBusiness Wire, 2022-05-25COPYRIGHT 2022 Business Wire, Inc.Digital Resources/Online E-Resources |
| 9 |
Material Type: Newspaper Article
|
|
Hypertrophic Cardiomyopathy Pipeline Research Report 2023 Featuring Cytokinetics, Imbria, Bristol-Myers Squibb, Tenaya Therapeutics, Lexeo Therapeutics, and BioMarinPR newswire, 2023-12-13COPYRIGHT 2023 PR Newswire Association LLCDigital Resources/Online E-Resources |
| 10 |
Material Type: Newspaper Article
|
|
BridgeBio Pharma Inc at JPMorgan Healthcare Conference - FinalFair Disclosure Wire, 2024-01-08Copyright CQ Roll Call Jan 8, 2024Digital Resources/Online E-Resources |
| 11 |
Material Type: Newspaper Article
|
|
Dilated Cardiomyopathy Market to Boost at a CAGR of approximately 13% by 2032 | DelveInsightPR newswire, 2022-07-11COPYRIGHT 2022 PR Newswire Association LLCDigital Resources/Online E-Resources |
| 12 |
Material Type: Newspaper Article
|
|
Hypertrophic Cardiomyopathy Treatment Market to Exhibit Impressive Growth by 2023, Predicts DelveInsight | Key Companies - Cytokinetics, Bristol-Myers Squibb, Imbria PharmaceuticalsM2 Presswire, 2024-03-06COPYRIGHT 2024 Normans Media Ltd.Digital Resources/Online E-Resources |
| 13 |
Material Type: Newspaper Article
|
|
Clinical Development News, Aug. 29-Sept. 2The Wall Street journal. Eastern edition, 2016-09-02(c) 2016 Dow Jones & Company, Inc. Reproduced with permission of copyright owner. Further reproduction or distribution is prohibited without permission. ;EISSN: 2574-9579Digital Resources/Online E-Resources |
| 14 |
Material Type: Newspaper Article
|
|
Hypertrophic Cardiomyopathy Marketed and Emerging Pipeline Drugs Assessment, 2023 | Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Treatment Outlook, Competitive Landscape, and Key CompaniesM2 Presswire, 2023-03-07COPYRIGHT 2023 Normans Media Ltd.Digital Resources/Online E-Resources |
| 15 |
Material Type: Newspaper Article
|
|
Alnylam's (ALNY) Impressive Pipeline Drives Share PriceZacks Investment Research [BLOG], 2019-03-18Copyright Newstex Mar 18, 2019Digital Resources/Online E-Resources |
| 16 |
Material Type: Newspaper Article
|
|
Pfizer's VYNDAQEL Reduced the Risk of All-Cause Mortality by 41% Among Patients with Transthyretin Amyloid Cardiomyopathy, Five-Year Follow-Up Data DemonstrateBusiness Wire, 2021-12-20COPYRIGHT 2021 Business Wire, Inc.Digital Resources/Online E-Resources |
| 17 |
Material Type: Newspaper Article
|
|
Pfizer's VYNDAQEL[R]/VYNDAMAX[R] Reduced the Risk of All-Cause Mortality by 41% Among Patients with Transthyretin Amyloid Cardiomyopathy, Five-Year Follow-Up Data DemonstrateBusiness Wire, 2021-12-20COPYRIGHT 2021 Business Wire, Inc.Digital Resources/Online E-Resources |
| 18 |
Material Type: Newspaper Article
|
|
Sanofi, MyoKardia Team Up To Develop Therapies For Genetic Heart DiseaseRTTNews, 2014-09-17Copyright (c) 2014 RTT NewsDigital Resources/Online E-Resources |
| 19 |
Material Type: Newspaper Article
|
|
Bristol Myers Squibb Shares Research Supporting Correlation Between New York Heart Association Functional Class (NYHA class) and Mortality in Obstructive Hypertrophic CardiomyopathyBusiness Wire, 2021-09-11COPYRIGHT 2021 Business Wire, Inc.Digital Resources/Online E-Resources |
| 20 |
Material Type: Newspaper Article
|
|
Lexicon Pharmaceuticals Inc Investor Day - FinalFair Disclosure Wire, 2024-04-22Copyright CQ Roll Call Apr 22, 2024Digital Resources/Online E-Resources |
Results 1 - 20 of 62 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Refine My Results
Creation Date
- Before 2014 (2)
- 2014 To 2015 (3)
- 2016 To 2017 (6)
- 2018 To 2020 (11)
- After 2020 (41)
-
More options
New Records
Subject
- Cardiomyopathy (31)
- Cardiomyopathy, Hypertrophic (25)
- Drugs (11)
- Heart Diseases (10)
- Business (10)
- Muscle Proteins (10)
- Myosin (10)
- Product Development (9)
- Care And Treatment (9)
- Forecasts And Trends (9)
- Amyloidosis (8)
- Clinical Trials (7)
- Drug Approval (7)
- Cardiac Patients (6)
- Epidemiology (6)
- Drug Therapy (6)
- Biotechnology Industry (5)
- Disease (5)
- Cancer Therapies (5)
-
More options
Journal Title
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||